Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

President to Nominate Pennsylvania Congressman Tom Marino as U.S. Drug Czar

Rep. Tom Marino

Washington, DC, September 5, 2017 — The White House on Friday announced that President Donald Trump will nominate Congressman Tom Marino, a Pennsylvania Republican, to head the the Office of National Drug Control Policy — a position better known as the nation’s drug czar.

In Congress, Marino has worked to expand access to treatment for people struggling with opioid addiction.

The 64-year-old congressman lives outside Williamsport, Pennsylvania, and is a former county prosecutor who served as U.S. attorney in Pennsylvania’s Middle District under President George W. Bush.

Marino was an early supporter of President Trump and the first Pennsylvania congressman to endorse Trump in the presidential primary contest.

This is not the first time that Marino’s name had been advanced for the drug czar position.

In April, CBS News reported that Rep. Marino, a former elected county prosecutor and U.S. attorney, was under consideration for the position.

The Washington Examiner reported that Marino’s name, in May, was dropped from consideration in May under circumstances that remain murky, after issues from his past resurfaced in the press.

In May, Marino’s office initially refused to comment, but Marino later told local publications his mother had a serious heart condition.

“I can’t live in D.C. Monday through Friday,” he said. “I have to be here for my mother.”

However, Marino said he would remain a member of Congress to “continue to support President Trump in whatever way I can.”

Marino chief of staff Sara Rogers did not immediately respond to a request for comment on why Marino again decided to pursue the office and whether he views the scandals as legitimate questions ahead of Senate confirmation hearings.

For the full story from the Examiner, click here.